From the Journals
From the Journals
Does metformin reduce risk for death in COVID-19?
“It is still unclear whether metformin is truly a miracle drug or whether it is simply used more often among people who are healthier and who do...
From the Journals
Determining cause of skin lesions in COVID-19 patients remains challenging
“By considering adverse drug reactions in the differential diagnosis, dermatologists can be useful in assisting in the care of these patients.”
From the Journals
Since COVID-19 onset, admissions for MI are down, mortality rates are up
From the Journals
Studies gauge role of schools, kids in spread of COVID-19
A look at the effect of the school closures at the start of the pandemic in the United States.
Guidelines
Guidance covers glycemia in dexamethasone-treated COVID-19 patients
The latest document from the COVID-19 response group of the Association of British Clinical Diabetologists is a response to the recent RECOVERY...
From the Journals
Educational intervention curbs use of antibiotics for respiratory infections
Modules involving online webinars, tutorials, and feedback helped reduce antibiotic prescribing in pediatric clinics.
From the Journals
Many children with COVID-19 present without classic symptoms
Of 22 children hospitalized and positive for SARS-CoV-2, most had no respiratory illness or symptoms.
From the Journals
Posaconazole prophylaxis was effective in children with ALL undergoing chemotherapy
Targeted posaconazole prophylaxis was effective in preventing invasive fungal infection in children with ALL undergoing induction chemotherapy.
From the Journals
Cutaneous clues linked to COVID-19 coagulation risk
These skin signs could augment coagulation assays in this patient population.
From the Journals
Hepatitis screening now for all patients with cancer on therapy
All patients with cancer who are candidates for systemic therapy should be screened for hepatitis B, says the American Society of Clinical...
From the Journals
COVID-19 taking financial toll on people in U.S. with diabetes
Unemployment and income loss caused by the pandemic are higher among those with diabetes than in the general U.S. population.